Effect Of Flunarizine Hydrochloride On The Treatment Of Cerebral Vasospasm Headache And Serum Nse, Crp, Fabp

Liya Gong,Ya Wang,Hong Qi
DOI: https://doi.org/10.19193/0393-6384_2021_5_439
2021-01-01
Acta medica mediterranea
Abstract:Objective: We sought to explore the effect of flunarizine hydrochloride on the treatment of cerebral vasospasm headache and serum nerve-specific enolase (NSE), C-reactive protein (CRP), and fatty acidbinding protein (FABP) concentrations.Methods: A total of 160 patients with cerebral vasospasm headache admitted to our hospital from October 2017 to March 2019 were identified for comparative treatment. According to the random number method, study participants were divided into the treatment group (n = 80 cases) and the control group (n = 80 cases). The control group was treated with nimodipine, while the treatment group was treated with flunarizine hydrochloride. The clinical efficacy of patients after treatment; the serum NSE, CRP, FABP, tumor necrosis factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta), nitric oxide, and thromboxane B-2 (TXB2) concentrations; and the middle cerebral artery blood flow velocity were compared and analyzed.Results: After treatment, the total effective rate of the study group was significantly higher than that of the control group and the difference was statistically significant (P<0.05). The levels of NSE, CRP, and FABP in the two groups were significantly lower than those before treatment, while the above indices in the treatment group were statistically significantly lower than those in the control group (P<0.05). On the fourth and eighth days after treatment, the levels of TNF-alpha and IL-1 beta in the two groups were significantly lower than those before treatment and the above indices in the treatment group were significantly lower than those in the control group (P<0.05); moreover, the level of NO was significantly higher than that before treatment and the above indices in the treatment group were significantly higher than those in the control group (P<0.05). On the fourth day after treatment, the level of TXB2 in both groups was significantly higher than that before treatment (P<0.05). Meanwhile, on the eighth day after treatment, the level of TXB2 was significantly lower than that on the fourth day after treatment and the above indices in the treatment group were significantly lower than those in the control group (P<0.05). On the fourth and eighth days after treatment, the blood flow velocity of the middle cerebral artery in the two groups was significantly lower than that before treatment and the above indices in the treatment group were significantly lower than those in the control group (P<0.05).Conclusion: Flunarizine hydrochloride in the treatment of vasospasm headache can effectively reduce the headache symptoms, alleviate the cerebral ischemia and hypoxia injury, improve the cerebral circulation, reduce the cerebral blood flow speed, promote the recovery of cerebral blood flow, improve the vascular tension, and limit the level of inflammatory factors and neurological damage. It shows good clinical effect and is worthy of clinical application.
What problem does this paper attempt to address?